Perioperative chemotherapy with docetaxel, cisplatin, and capecitabine (DCX) in gastroesophageal adenocarcinoma: A phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
P. C. Thuss-Patience
Consultant or Advisory Role - Roche; Sanofi
Honoraria - Roche; Sanofi
Research Funding - Roche; Sanofi
R. Hofheinz
Honoraria - Roche; Sanofi
D. Arnold
Consultant or Advisory Role - Roche; Sanofi
Honoraria - Roche; Sanofi
Research Funding - Roche; Sanofi
A. Florschütz
No relevant relationships to disclose
S. Daum
No relevant relationships to disclose
A. Kretzschmar
No relevant relationships to disclose
L. Mantovani-Löffler
No relevant relationships to disclose
D. Bichev
No relevant relationships to disclose
B. Gahn
No relevant relationships to disclose
G. Schumacher
No relevant relationships to disclose
M. Kneba
No relevant relationships to disclose